DuoTrav Combination Ophthalmic Solution(デュオトラバ配合点眼液)
DuoTrav Combination Ophthalmic Solution(Travoprost/Timolol Maleate)
Brand name : DuoTrav Combination Ophthalmic Solution
Active ingredient: Travoprost/timolol maleate
Dosage form: colorless to slightly yellow, limpid, ophthalmic solution; (plastic bottle) 2.5mL; (cap) dark blue
Print on wrapping:
Effects of this medicine
This medicine suppresses production of aqueous humor and promotes aqueous humor outflow in order to lower intraocular pressure and avoid visual field loss.
It is usually used to treat glaucoma or ocular hypertension.
Before using this medicine, be sure to tell your doctor and pharmacist
•If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have: asthma or its hstory, bronchospasm...acidosis, aphakic or pseudophakic eye, intraocular inflammation (iritis, uveitis).
If you wear contact lenses.
•If you are pregnant or breastfeeding.
•If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
•Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>>
•In general, apply 1 drop at a time, once a day. Strictly follow the instructions.
•Before applying eye-drops, wash your hands thoroughly. Take care not to touch the dropper tip against the eye when applying.
•After dropping the solution into your eyes, keep your eyes closed for 1 to 5 minutes pressing your inner corner of the eyes lightly. Wipe off any excess liquid with a clean tissue, or wash your face.
•If you need to use other eye drops at the same time, take more than 5 minutes intervals between medicines.
•If you miss a dose, apply the missed dose as soon as possible in case of the same day. If you aware the next day, you do not need to apply twice a day nor two drops at one time. You should not apply two doses at one time.
•If you accidentally use more than your prescribed dose, consult with your doctor or pharmacist.
•Do not stop using this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
•The medicine may cause blurred vision temporarily. Do not drive a car or operate machinery until these symptoms recover.
Possible adverse reactions to this medicine
The most commonly reported adverse reactions include red eyes, eye irritation, eyelid skin darkening, itchy eyes, keratitis, hair appearing around eye area, blurred vision, abnormal sensation in eyes, foreign body sensation in eyes, dry eye, eye pain, photophobia, iritis and deepening of the eyelid sulcus (hollow of upper eyelid, fall to double-fold eyelid etc.). If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
•changes in the color of the iris [iris pigmentation]
•foreign body sensation in eyes, eye pain [ocular pemphigoid]
•short breath, choking, stridor [bronchospasm, dyspnea, respiratory failure]
•dyspnea, unconsciousness, dizziness on standing up [cardiac block, congestive heart failure, brain ischemia, cardiac asystole, cerebrovascular disorder]
•general malaise, fever, erythema that gets worse when in sunlight [systemic lupus erythematosus]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
•Keep out of the reach of children. Store away from heat and direct sunlight. Store at room temperature (1 to 30℃) in a storage bag.
•Discard the remainder. Do not store them. Do not use any medicine that has been stored for more than 4 weeks after opening.
ALCON JAPAN LIMITEDExternal
Revised: 4/2016
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
http://www.info.pmda.go.jp/go/pack/1319820Q1022_1_08/ |
|